PCM
IDIX

Prelude Capital Management’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Prelude Capital Management’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-8,700
Closed -$45K – 2196
2013
Q3 		$45K Buy
+8,700
New +$38.1K 0.01% 944

Prelude Capital Management's IDIX Position: Q3 2014 in Review

Prelude Capital Management sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 110,928 shares — an estimated $2.67M sold.

Prelude Capital Management first reported a position in IDIX in Q3 2013 and held it in 2 quarters. The position peaked at $2.67M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • Prelude Capital Management reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Prelude Capital Management sold 110,928 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $2.67M.
  • Prelude Capital Management first reported a position in IDENIX PHARMACEUTICALS INC in Q3 2013 and held it in 2 quarters.
  • Prelude Capital Management's IDENIX PHARMACEUTICALS INC position peaked at $2.67M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Prelude Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.